Farallon Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $192M | Buy |
|
|||||
|
2025
Q1 | $167M | Buy |
|
|||||
|
2024
Q4 | $186M | Buy |
|
|||||
|
2024
Q3 | $252M | Buy |
|
|||||
|
2024
Q2 | $244M | Buy |
|
|||||
|
2024
Q1 | $163M | Buy |
|
|||||
|
2023
Q4 | $92.8M | Buy |
|
|||||
|
2023
Q3 | $68.1M | Buy |
|
|||||
|
2023
Q2 | $76.1M | Buy |
|
|||||
|
2023
Q1 | $48.1M | Buy |
|
|||||
|
2022
Q4 | $56.9M | Buy |
|
|||||
|
2022
Q3 | $42.3M | Buy |
|
|||||
|
2022
Q2 | $29.6M | Hold |
|
|||||
|
2022
Q1 | $38.8M | Buy |
|
|||||
|
2021
Q4 | $41.3M | Buy |
|
|||||
|
2021
Q3 | $37.8M | Sell |
|
|||||
|
2021
Q2 | $63.9M | Sell |
|
|||||
|
2021
Q1 | $64.5M | Buy |
|
|||||
|
2020
Q4 | $43.3M | Sell |
|
|||||
|
2020
Q3 | $37.9M | Sell |
|
|||||
|
2020
Q2 | $66.8M | Hold |
|
|||||
|
2020
Q1 | $44.4M | Hold |
|
|||||
|
2019
Q4 | $59.7M | Buy |
|